Research

The Prophylactic Antiobiotic Regimens in Tumor Surgery (PARITY)

www.PARITYtrial.com

MSTS is funding (2012-14) the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Pilot Randomized MultiCenter Clinical Trial. The PI is Michelle Ghert, MD and is coordinated by the Center for Evidence-Based Orthopaedics at McMaster University. The trial is an international, multicenter randomized double-blind surgical trial in which patients undergoing endoprosthetic reconstruction of the lower extremity are randomized to either short-term (24 hours) or long-term (5 days) postoperative antibiotics. The primary endpoint is deep infection within the first year following implantation. Investigator orientation occurred this fall and patient accrual has started. Six North American sites have the study open. Five states in the UK (representing well over 100 cases per year) are planning to participate. A site in Buenos Aires is active and we have sites in Japan and Israel 'in the queue' for funding.

Interested in participating? Contact Michelle Ghert, MD via email at Michelle.Ghert@jcc.hhsc.ca, as all MSTS sponsored studies are open to all MSTS members.

 

2015 Annual Meeting

October 6-10
MSTS/ISOLS

Orlando, FL




Support MSTS

Learn how you can help support the Musculoskeletal Tumor Society.

For The Patient

 Links

 Tumor Information

Become a Member

Join MSTS